APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 59 filers reported holding APTEVO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,000 | +50.0% | 3,563 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | -20.0% | 3,563 | 0.0% | 0.00% | – |
| Q4 2017 | $15,000 | +87.5% | 3,563 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | +14.3% | 3,563 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | 0.0% | 3,563 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | -22.2% | 3,563 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | 0.0% | 3,563 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | – | 3,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,920,368 | $4,686,000 | 0.88% |
| Fondren Management LP | 388,355 | $948,000 | 0.68% |
| Perceptive Advisors | 988,133 | $2,411,000 | 0.17% |
| CSS LLC/IL | 353,977 | $864,000 | 0.05% |
| GLG Partners LP | 357,834 | $873,000 | 0.04% |
| Acrospire Investment Management LLC | 23,144 | $56,000 | 0.02% |
| Laurel Wealth Advisors, Inc. | 16,850 | $41,000 | 0.02% |
| Capital Impact Advisors, LLC | 12,318 | $30,000 | 0.01% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 43,559 | $106,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $24,000 | 0.01% |